Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Sex- and Age-Related Differences in the Contribution of Ultrasound-Measured Visceral and Subcutaneous Abdominal Fat to Fatty Liver Index in Overweight and Obese Caucasian Adults.

Leone A, Battezzati A, Bedogni G, Vignati L, Vanzulli A, De Amicis R, Foppiani A, Bertoli S.

Nutrients. 2019 Dec 9;11(12). pii: E3008. doi: 10.3390/nu11123008.

2.

Association of Binge Eating Behavior with Total and Abdominal Adipose Tissue in a Large Sample of Participants Starting a Weight Loss or Maintenance Program.

Leone A, Vignati L, Battezzati A, De Amicis R, Ponissi V, Beggio V, Bedogni G, Vanzulli A, Bertoli S.

J Am Coll Nutr. 2018 Apr 27:1-7. doi: 10.1080/07315724.2018.1463184. [Epub ahead of print]

PMID:
29702028
3.

Association of Body Shape Index (ABSI) with cardio-metabolic risk factors: A cross-sectional study of 6081 Caucasian adults.

Bertoli S, Leone A, Krakauer NY, Bedogni G, Vanzulli A, Redaelli VI, De Amicis R, Vignati L, Krakauer JC, Battezzati A.

PLoS One. 2017 Sep 25;12(9):e0185013. doi: 10.1371/journal.pone.0185013. eCollection 2017.

4.

The Sustained Effects of a Dual GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes.

Frias JP, Bastyr EJ 3rd, Vignati L, Tschöp MH, Schmitt C, Owen K, Christensen RH, DiMarchi RD.

Cell Metab. 2017 Aug 1;26(2):343-352.e2. doi: 10.1016/j.cmet.2017.07.011.

5.

Association between ratio indexes of body composition phenotypes and metabolic risk in Italian adults.

Powell M, Lara J, Mocciaro G, Prado CM, Battezzati A, Leone A, Tagliabue A, de Amicis R, Vignati L, Bertoli S, Siervo M.

Clin Obes. 2016 Dec;6(6):365-375. doi: 10.1111/cob.12165. Epub 2016 Nov 21.

PMID:
27869360
6.

Metabolic correlates of subcutaneous and visceral abdominal fat measured by ultrasonography: a comparison with waist circumference.

Bertoli S, Leone A, Vignati L, Spadafranca A, Bedogni G, Vanzulli A, Rodeschini E, Battezzati A.

Nutr J. 2016 Jan 6;15:2. doi: 10.1186/s12937-015-0120-2.

7.

Adherence to the Mediterranean diet is inversely associated with visceral abdominal tissue in Caucasian subjects.

Bertoli S, Leone A, Vignati L, Bedogni G, Martínez-González MÁ, Bes-Rastrollo M, Spadafranca A, Vanzulli A, Battezzati A.

Clin Nutr. 2015 Dec;34(6):1266-72. doi: 10.1016/j.clnu.2015.10.003. Epub 2015 Oct 20.

PMID:
26499033
8.

Taste sensitivity, nutritional status and metabolic syndrome: Implication in weight loss dietary interventions.

Bertoli S, Laureati M, Battezzati A, Bergamaschi V, Cereda E, Spadafranca A, Vignati L, Pagliarini E.

World J Diabetes. 2014 Oct 15;5(5):717-23. doi: 10.4239/wjd.v5.i5.717.

9.

Relationship between thyroid hormones, resting energy expenditure and cardiometabolic risk factors in euthyroid subjects.

Spadafranca A, Cappelletti C, Leone A, Vignati L, Battezzati A, Bedogni G, Bertoli S.

Clin Nutr. 2015 Aug;34(4):674-8. doi: 10.1016/j.clnu.2014.07.014. Epub 2014 Aug 4.

PMID:
25176403
10.

Relevance of Mediterranean diet and glucose metabolism for nephrolithiasis in obese subjects.

Soldati L, Bertoli S, Terranegra A, Brasacchio C, Mingione A, Dogliotti E, Raspini B, Leone A, Frau F, Vignati L, Spadafranca A, Vezzoli G, Cusi D, Battezzati A.

J Transl Med. 2014 Feb 6;12:34. doi: 10.1186/1479-5876-12-34.

11.

Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans.

Finan B, Ma T, Ottaway N, Müller TD, Habegger KM, Heppner KM, Kirchner H, Holland J, Hembree J, Raver C, Lockie SH, Smiley DL, Gelfanov V, Yang B, Hofmann S, Bruemmer D, Drucker DJ, Pfluger PT, Perez-Tilve D, Gidda J, Vignati L, Zhang L, Hauptman JB, Lau M, Brecheisen M, Uhles S, Riboulet W, Hainaut E, Sebokova E, Conde-Knape K, Konkar A, DiMarchi RD, Tschöp MH.

Sci Transl Med. 2013 Oct 30;5(209):209ra151. doi: 10.1126/scitranslmed.3007218.

12.

Oral protein kinase c β inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study 2.

Aiello LP, Vignati L, Sheetz MJ, Zhi X, Girach A, Davis MD, Wolka AM, Shahri N, Milton RC; PKC-DRS and PKC-DRS2 Study Groups.

Retina. 2011 Nov;31(10):2084-94. doi: 10.1097/IAE.0b013e3182111669.

PMID:
21862954
13.

Sustained moderate visual loss as a predictive end point for visual loss in non-proliferative diabetic retinopathy.

Girach A, Aiello LP, Milton RC, Davis MD, Danis RP, Zhi X, Sheetz MJ, Vignati L; PKC-DRS2 Study Group.

Eye (Lond). 2009 Jan;23(1):209-14. doi: 10.1038/eye.2008.324. Epub 2008 Nov 7.

PMID:
18989348
14.

Effect of ruboxistaurin on the visual acuity decline associated with long-standing diabetic macular edema.

Davis MD, Sheetz MJ, Aiello LP, Milton RC, Danis RP, Zhi X, Girach A, Jimenez MC, Vignati L; PKC-DRS2 Study Group.

Invest Ophthalmol Vis Sci. 2009 Jan;50(1):1-4. doi: 10.1167/iovs.08-2473. Epub 2008 Aug 15.

PMID:
18708615
15.

Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy.

PKC-DRS2 Group, Aiello LP, Davis MD, Girach A, Kles KA, Milton RC, Sheetz MJ, Vignati L, Zhi XE.

Ophthalmology. 2006 Dec;113(12):2221-30. Epub 2006 Sep 20.

PMID:
16989901
16.

Diabetic microvascular complications--can the presence of one predict the development of another?

Girach A, Vignati L.

J Diabetes Complications. 2006 Jul-Aug;20(4):228-37. Review.

PMID:
16798474
17.

An in vitro approach to detect metabolite toxicity due to CYP3A4-dependent bioactivation of xenobiotics.

Vignati L, Turlizzi E, Monaci S, Grossi P, Kanter Rd, Monshouwer M.

Toxicology. 2005 Dec 15;216(2-3):154-67. Epub 2005 Sep 19.

PMID:
16169652
18.
19.

Cytotoxic alpha-bromoacrylic derivatives of low molecular weight.

Beria I, Caldarelli M, Geroni C, Mongelli N, Reinach B, Vignati L, Cozzi P.

Bioorg Med Chem Lett. 2002 Jun 3;12(11):1467-71.

PMID:
12031321
20.

Development of a lipid-rich, soft plaque in rabbits, monitored by histology and intravascular ultrasound.

Chiesa G, Di Mario C, Colombo N, Vignati L, Marchesi M, Monteggia E, Parolini C, Lorenzon P, Laucello M, Lorusso V, Adamian M, Franceschini G, Newton R, Sirtori CR.

Atherosclerosis. 2001 Jun;156(2):277-87.

PMID:
11395023
21.

Factors associated with nocturnal hypoglycaemia among patients with type 2 diabetes new to insulin therapy: experience with insulin lispro.

Bastyr EJ 3rd, Huang Y, Brunelle RL, Vignati L, Cox DJ, Kotsanos JG.

Diabetes Obes Metab. 2000 Jan;2(1):39-46.

PMID:
11220353
22.

Insulin lispro in the treatment of patients with type 2 diabetes mellitus after oral agent failure.

Bastyr EJ 3rd, Johnson ME, Trautmann ME, Anderson JH Jr, Vignati L.

Clin Ther. 1999 Oct;21(10):1703-14.

PMID:
10566566
23.

Basal activity profiles of NPH and [Nepsilon-palmitoyl Lys (B29)] human insulins in subjects with IDDM.

Radziuk J, Pye S, Bradley B, Braaten J, Vignati L, Roach P, Bowsher R, DiMarchi R, Chance R.

Diabetologia. 1998 Jan;41(1):116-20. Erratum in: Diabetologia 1998 Apr;41(4):489-90.

PMID:
9498640
25.

Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.

Anderson JH Jr, Brunelle RL, Keohane P, Koivisto VA, Trautmann ME, Vignati L, DiMarchi R.

Arch Intern Med. 1997 Jun 9;157(11):1249-55.

PMID:
9183237
26.

Health-related quality-of-life results from multinational clinical trials of insulin lispro. Assessing benefits of a new diabetes therapy.

Kotsanos JG, Vignati L, Huster W, Andrejasich C, Boggs MB, Jacobson AM, Marrero D, Mathias SD, Patrick D, Zalani S, Anderson J.

Diabetes Care. 1997 Jun;20(6):948-58.

PMID:
9167105
27.

Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group.

Anderson JH Jr, Brunelle RL, Koivisto VA, Pfützner A, Trautmann ME, Vignati L, DiMarchi R.

Diabetes. 1997 Feb;46(2):265-70.

PMID:
9000704
28.

Improved mealtime treatment of diabetes mellitus using an insulin analogue. Multicenter Insulin Lispro Study Group.

Anderson JH Jr, Brunelle RL, Koivisto VA, Trautmann ME, Vignati L, DiMarchi R.

Clin Ther. 1997 Jan-Feb;19(1):62-72.

PMID:
9083709
29.

Serum leptin levels in women with anorexia nervosa.

Grinspoon S, Gulick T, Askari H, Landt M, Lee K, Anderson E, Ma Z, Vignati L, Bowsher R, Herzog D, Klibanski A.

J Clin Endocrinol Metab. 1996 Nov;81(11):3861-3.

PMID:
8923829
30.

The antidiabetogenic effect of GLP-1 is maintained during a 7-day treatment period and improves diabetic dyslipoproteinemia in NIDDM patients.

Juntti-Berggren L, Pigon J, Karpe F, Hamsten A, Gutniak M, Vignati L, Efendic S.

Diabetes Care. 1996 Nov;19(11):1200-6.

PMID:
8908380
31.

Pre-meal insulin analogue insulin lispro vs Humulin R insulin treatment in young subjects with type 1 diabetes.

Garg SK, Carmain JA, Braddy KC, Anderson JH, Vignati L, Jennings MK, Chase HP.

Diabet Med. 1996 Jan;13(1):47-52.

PMID:
8741812
32.

[The noninvasive assessment of the effects of penbutolol on liver hemodynamics in cirrhotic patients using angioscintigraphy. A randomized controlled double-blind study].

Santambrogio R, Opocher E, Bruno S, Chiesa A, Gagliano G, Rossi S, Grugni MC, Zatta G, Bestetti A, Vignati L, et al.

Recenti Prog Med. 1990 Nov;81(11):705-9. Italian.

PMID:
1962892
33.
34.

Continuous subcutaneous insulin therapy during early pregnancy.

Kitzmiller JL, Younger MD, Hare JW, Phillippe M, Vignati L, Fargnoli B, Grause A.

Obstet Gynecol. 1985 Nov;66(5):606-11.

PMID:
4058818
35.

Questions and answers on diabetes. A panel discussion.

Bower BF, Flier J, Vignati L, Felig P.

Trans Assoc Life Insur Med Dir Am. 1985;68:66-71. No abstract available.

PMID:
4090146
36.

Insulin pumps: when are they indicated, what can they do?

Vignati L.

Trans Assoc Life Insur Med Dir Am. 1985;68:53-60. No abstract available.

PMID:
4090144
37.

Abnormal results of dexamethasone suppression tests in nondepressed patients with diabetes mellitus.

Hudson JI, Hudson MS, Rothschild AJ, Vignati L, Schatzberg AF, Melby JC.

Arch Gen Psychiatry. 1984 Nov;41(11):1086-9. Erratum in: Arch Gen Psychiatry 1987 Jun;44(6):517.

PMID:
6497571
38.

Insulin pumps. The patients' verdict.

Fredholm N, Vignati L, Brown S.

Am J Nurs. 1984 Jan;84(1):36-8. No abstract available.

PMID:
6559029
39.

Protein conservation during prolonged fast: a function of triiodothyronine levels.

Vignati L, Finley RJ, Hagg S, Aoki TT.

Trans Assoc Am Physicians. 1978;91:169-79. No abstract available.

PMID:
382585

Supplemental Content

Loading ...
Support Center